Advanced Therapy Medicinal Products

(asked on 8th December 2022) - View Source

Question to the Department of Health and Social Care:

To ask His Majesty's Government whether they have made an assessment of the case for publishing an externally facing national strategy for Advanced Therapy Medicinal Products to support patient access.


Answered by
Lord Markham Portrait
Lord Markham
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 20th December 2022

No specific assessment has been made. However, NHS England is supporting companies to develop cost-effective value propositions Advanced Therapy Medicinal Products (ATMPs) for the National Institute for Health and Care Excellence (NICE) and the rapid introduction of all ATMPs recommended by NICE to date.

The Cell and Gene Therapy Catapult and the UK Strategic Stem Cell Forum have made recommendations to the Government on the adoption of gene therapy and ATMPs to ensure the United Kingdom maintains a global advantage. The Department is considering these recommendations.

Reticulating Splines